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[57] ABSTRACT 
An oscillating capillary nebulizer with electrospray which is 
capable of nebulizing a liquid sample flow at microflow and 
normal liquid flow rates. The oscillating capillary nebulizer 
with electrospray comprises a pair of coaxial capillary tubes 
which are friction-fit mounted by way of peek tubing 
ferrules. A source of electric potential is connected to the 
inner capillary for production of an electric field in the 
vicinity of the distal end of the inner capillary. The dimen-
sions of the inner and outer capillary tubes are such that an 
annular spacing is created between the inner surface of the 
outer capillary tube and the outer surface of inner capillary 
tube. A liquid sample is introduced into the nebulizer 
through the inner capillary tube. A gas flow path is provided 
by the space between the inner and outer capillary tubes. The 
gas enters the gas flow path through a port in the side of the 
outer capillary tube. At least the inner capillary tube is made 
of flexible material. Preferably, the inner diameter of the 
inner capillary tube is small enough to provide jet flow of the 
liquid sample at low liquid flow rates. The gas flow velocity, 
which is a function of the gas flow rate and the size of the 
annular spacing, is sufficient to cause turbulence of the gas 
stream around the free end of the inner capillary tube, 
thereby creating instability in the system. This instability, 
depending on how the system is set up, will initially cause 
the inner capillary tube to oscillate. The oscillation causes 
the generation of a high frequency standing wave along a 
portion of the length of the inner capillary and a breakup of 
the liquid jet into uniform liquid drop sizes. 
13 Claims, 12 Drawing Sheets 
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OSCILLATING CAPILLARY NEBULIZER 
WITH ELECTROSPRAY 
RELATED APPLICATIONS 
2 
liquid sample flow rate was optimized at 120 µl/min. with a 
corresponding gas nebulizer gas pressure of 200 psi and a 
nebulizer gas flow rate of 1.0 µL/min. In operation, Wiederin 
et al. observed a slight hissing sound, like most pneumatic 
5 nebulzers, which became quite loud when the plasma was 
started and liquids were nebulized. Wiederin et al. comments 
that the precision of their nebulizer was notably poorer when 
positioned in a spray chamber similar to a conventional 
This application is a continuation-in-part of U.S. appli-
cation Ser. No. 08/370,734, filed Jan. 10, 1995 now U.S. Pat. 
No. 5,725,153 and a continuation-in-part of U.S. application 
Ser. No. 08/946,784, filed Oct. 7, 1997 now U.S. Pat. No. 
5,848,751 which is a division of U.S. application Ser. No. 10 
08/370,734 filed Jan. 10, 1995. 
FIELD OF THE INVENTION 
pneumatic nebulizer. 
The operation of the Wiederin et al. DIN assembly has 
been categorized by Shum et al. See Appl. Spectrosc. 47, 
575, (1993). When the Wiederin et al. DIN assembly was 
operated at a liquid flow rate of 100 µL/min., it was found 
that the inclusion of methanol as an organic modifier to a The present invention relates to a method and apparatus 
for generating an aerosol and, more particularly, an oscil-
lating capillary nebulizer with electrospray which is capable 
of nebulizing a liquid flow at low and microflow liquid flow 
rates and controlling the particle size and the particle size 
distribution of the nebulized particles. 
15 liquid water sample had a dramatic effect on the size of the 
aerosol droplet distribution attained, as illustrated by Shum 
et al. It was also observed that varying nebulizer gas flow 
rates from 0.3-0.9 L/min., while maintaining the liquid 
sample flow rate constant, had little effect on the size of 
20 aerosol droplets obtained. 
BACKGROUND OF THE INVENTION 
Typical pneumatic nebulizers, such as the Meinhard TR 
30-C3 nebulizer, operate at liquid sample flow rates of about 
500 µl/min or greater. The Meinhard nebulizer consists of a 
rigid inner glass capillary tube drawn to a fine tip, sur-
rounded by another glass tube drawn concentrically to a 
conical tip. The nebulizer operates through the interaction of 
a liquid stream in the inner capillary and a gas stream in the 
annular space-between the capillary tubes causing droplet 
formation. The Meinhard nebulizer suffers from a number of 
drawbacks, including that it tends to block up due to its 
converging tip. Once blocked, it is usually discarded. 
It is also known in the prior art to utilize ultrasonic 
transducers to break up a liquid sample jet into liquid 
droplets. For example, U.S. Pat. No. 4,112,297, to Miyagi et 
al., discloses a nebulizer which includes an ultrasonic trans-
25 ducer used to create the particle beam. U.S. Pat. No. 
4,403,147, to Melera et al., incorporates an acoustic 
transducer, such as a piezoelectric transducer which may be 
used to stimulate the probe to break up the liquid stream. An 
example of a nebulizer which employs an oscillating piezo-
30 electric ceramic transducer is disclosed in U.S. Pat. No. 
Nebulizers which employ parallel coaxial tubes tend to 
avoid blockage problems. One such nebulizer is that of the 35 
application GB 2 203 241 to Willoughby et al. In this 
nebulizer velocity of the entraining gas combined with 
thermally induced solvent evaporation serves to cause a 
breakup of the liquid sample jet into liquid particles to 
produce an aerosol. This nebulizer is described to operate 40 
over liquid sample flow rates from 10-2000 µl/min. 
However, such nebulizers are not known to work well at low 
liquid flow rates or when the end of the inner capillary tube 
extends out beyond the end of the outer capillary tube. By 
low liquid flow rates, we mean 500 µl/min or less. This 45 
nebulizer is not described to cause an oscillation of the 
3,790,079 to Berglund. In such nebulizers, which operate on 
the basis of a transducer, the frequency of operation effects 
the aerosol droplet size. They also are much more expensive 
than a coaxial tube nebulizer. 
U.S. Pat. No. 3,108,749, to Draver et al., and Reissue 
patent RE.25,744, to Drayer et al., are representative of other 
forms of pressurized air induced vibrating atomizers. 
None of the above described nebulizers or atomizers are 
known to operate reliably at microflow liquid flow rates. By 
microflow liquid flow rates, we mean 100 µl/min or less and 
preferably below 30 µl/min. Conventional nebulizers typi-
cally operate at liquid flow rates greater than 500 µl/min. 
However, at such liquid flow rates the solvent delivery rate 
to any mass spectrometer or plasma source detector will be 
so great as to cause considerable source instability. Hence, 
a solvent removal step, through either a droplet removal 
chamber or a two-(or three-)stage pressure reduction skin-
mer device is necessary. With benchtop liquid 
capillary tube by creating instability in the system, but rather 
describes that the aerosol is created by the combination of 
the entraining gas velocity and liquid sample heating. 
Another example of a known nebulizer which incorporates 
a coaxial tube arrangement is disclosed in U.S. Pat. No. 
4,924,097 to Browner et al. 
Another form of such a nebulizer is the direct injection 
nebulizer (DIN) of Wiederin et al. for inductively coupled 
plasma mass spectrometry (ICP/MS). Anal. Chem., 63, 
219-225 (1991). Wiederin et al. discloses a DIN assembly 
consisting of a length of fused silica capillary tubing having 
50 chromatography/mass spectrometry systems (LC/MS), the 
relatively low pumping capacity of the source makes cou-
pling with high flow nebulizers impractical. At liquid flow 
rates of about 500 µl/min or less, the conventional nebulizer 
becomes unsatisfactory and unreliable. The lowest liquid 
55 flow rate reported by Wiederin et al. for their direct injection 
nebulizer is 30 µl/min. However, they teach away from such 
lower flows by teaching that the liquid flow rate was 
optimized at 120 µl/min. a 50 µm inner diameter and a 200 µm outer diameter 
disposed within a stainless steel tube serving as the nebu-
lizer. The stainless steel tube has a 250 µm inner diameter 60 
and a 1.6 µm outer diameter. Thus, a 25 µm annular space is 
provided between the stainless steel tube and the fused silica 
capillary tubing. The inner tubing is positioned to extend 
approximately 100 µm beyond the end of the stainless steel 
nebulizer tube. The DIN assembly is positioned within the 65 
converging end of the quartz injector tube of the torch for 
injecting sample directly into the plasma of the ICP/MS. The 
It is important to recognize the relative definitions 
describing the range of velocities of the liquid flow. In 
inductively coupled plasma (ICP) work, conventional nebu-
lizers do well in relatively high liquid flow rates (defined 
here as 1-2 ml/min), but perform poorly in relatively low 
liquid flow rates (defined here as <100 µl/min). Conversely, 
the prior art oscillating capillary nebulizers ( OCN), perform 
well at low liquid flow rates compared to other devices in the 
fields of ICP/AES and ICP/MS. 
6,126,086 
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In reference to electrospray techniques, conventional 
sources use only high voltage to produce the aerosols 
described below. Therefore, the sources can only handle ~ 
very low flow (i.e., microflow) rate and a very low range of 
flow rates (1-15 µl/min). Accordingly, it will be understood 5 
by one skilled in the art that the descriptions "low" and 
"high" have different meanings relative to the different 
techniques (ICP or electrospray). 
It is known in the prior art to utilize an electrospray 
ionization technique which incorporates a fine capillary tube 10 
made of conducting metal attached to a high voltage source. 
In this technique, liquid is directed through the capillary tube 
in which the end is connected to one pole of a high voltage 
source. The end of the capillary tube is spaced from the 
orifice plate through which ions travel into the mass analyzer 15 
vacuum chamber. The capillary is connected to the pole of 
the high voltage source. The electric field generates charged 
droplets, and the droplets evaporate to produce ions. 
Examples of such a technique are disclosed in U.S. Pat. No. 
4,209,696 to Fite, and U.S. Pat. No. 4,861,988 to Henion et 20 
al. 
4 
compounds with very high mass. Since electrospray oper-
ate~ without the input of heat into the stray-ionization step, 
labile and polar samples are ionized without thermal deg-
radation. 
The combination of pneumatic nebulization in an electric 
field tolerates higher eluent flow rates and a higher percent-
age of water in the formation of a spray of charged droplets. 
In pure electrospray, a high electric field is required for both 
nebulization and charging. A second improvement over pure 
electrospray is that the nebulizer assistance allows a larger 
distance between the spray capillary and its counter 
electrode, which, together with the spray voltage, reduces 
the electric field at the tip and prevents a corona discharge 
even with nitrogen as the nebulizing gas. 
The present invention, unlike conventional electrospray, 
uses the OCN to assist in the production of charged droplets 
by the application of high voltage. The present invention, 
OCN/ESI, is better than conventional electrospray with 
respect to flow rate ranges and water content ranges in 
mobile phases. 
The present invention combines oscillating capillary 
nebulization with electrospray ionization. Accordingly, the 
present invention utilizes both an inner/outer coaxial tube 
In ICP/AES and ICP/MS, an OCN is used to produce and 
control the aerosols from the liquid. The aerosols then enter 
the plasma source and get excited/ionized, and finally, 
signals are generated by measuring the photons (AES) or 
ions (MS). In conventional electrospray, a high voltage is 
applied on the capillary. The high voltage produces charged 
aerosols, which then can be directly analyzed using a mass 
spectrometer. Therefore, electrospray is an ionization 
method, and may be used as an ion source. 
25 arran~ement, and means to produce an electrical field, for 
creatmg an aerosol at low and microflow liquid flow rates 
particularly for use with chromatographic techniques and for 
use with bench top LC/MS, ICP/AES and ICP/MS 
instruments, among others, and for controlling the particle 
30 size and particle size distribution of the aerosol. 
The present invention comprises a pair of coaxial capil-
lary tubes which are disposed in parallel to one another and 
which are preferably friction-fit mounted by way of PEEK 
tubing ferrules. The inner capillary tube comprises a con-
Yet, the conventional electrospray method has several 
dis~dvantages. Firstly, it can handle only a very small flow, 
typically only up to about 15 µl/min. Faster pumping pro-
duces larger droplets, thus causing the ion signal to fall off 
and also to become unstable. Secondly, the high voltages 
needed to disperse a larger liquid flow into fine droplets tend 
35 ducting material, while retaining an amount of flexibility. 
The inner capillary's proximal end is attached to a voltage 
source. The dimensions of the inner and outer capillary tubes 
are such that an annular spacing is created between the outer 
surface of the inner capillary tube and the inner surface of 
40 the outer capillary tube. A rotating connector ring or fitting 
may be included to allow the position of the inner capillary 
tube to be adjusted in the coaxial directions relative to the 
outer capillary tube. 
to create an electrical or corona discharge. The discharge 
adds complexity to the spectrum produced by the mass 
analyzer, causing difficulties in interpretation, and in 
addition, for unknown reasons, it tends to suppress the ion 
signals from the evaporated droplets. Other disadvantages 
are that dynamic range is usually less than two orders of 
magnitude, and that this process does not work well with 
additives. In addition, the electrospray method requires that 
the proportion of water in liquid be low, since otherwise a 45 
stream of large droplets tends to be produced. The large 
droplets reduce the sensitivity and also affects the stability of 
the ion signal, i.e. large fluctuations occur in the ion signal. 
Also, the prior art devices and methods tend to fail in 
performance and reliability as higher concentrations of 50 
water are used. 
Therefore, a need exists in the art for a nebulizer which is 
capable of producing an aerosol at microflow liquid flow 
rates for employment with microflow chromatographic tech-
niques and for use with bench top LC/MS, ICP/AES and 
ICP/MS instruments and which is capable of satisfactorily 
controlling the particle size and particle size distribution of 
the aerosol over wide concentration ranges of solvents and 
liquid flow rates, wider than those achievable with conven-
tional electrospray methods. Accordingly, the present inven-
tion employs an inner/outer coaxial tube arrangement uti-
lizing the electrospray technique which can meet these needs 
and overcome the above deficiencies. 
SUMMARY OF THE INVENTION 
Electrospray is an ionization technique for mass spec-
trometry that has the potential for producing ions even for 
A source of electric potential is connected to the inner 
capillary for production of an electric field in the vicinity of 
the distal end of the inner capillary. For negative ion 
operation, the high voltage may be kept in the range of 
-2000 to -3500 volts with the preferred range being -2500 
at -3000 volts, and for positive ion operation in the range of 
+2000 to +3500 volts with the preferred range being +2500 
to +3000 volts. The actual voltage applied will vary depend-
ing upon the analyte. 
A liquid sample is introduced into the nebulizer through 
the inner capillary tube. A gas flow path is provided by the 
55 annular space between the inner and outer capillary tubes. 
The gas enters the gas flow path through an opening in the 
side of the outer capillary tube. At least the inner capillary 
tube is made of a flexible material, preferably polyinide 
coated fused silica. This capillary may also be coated with 
60 a thin film of electrically conductive metal. The outer 
capillary tube may be made of either a flexible material or 
an inflexible material. Preferably, the inner diameter of the 
inner capillary tube is small enough to provide jet flow of the 
liquid sample at microflow liquid flow rates. The gas flow 
65 velocity, which is a function of both the gas flow rate and the 
size of the annular space, is sufficient to cause turbulence of 
the gas stream around the end of the inner capillary tube, 
6,126,086 
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In the preferred embodiment, the capillary tubes are 
replaceable in case of either breakage or blockage. 
thereby creating instability in the system. This instability, 
depending on how the system is set up, will initially cause 
the inner capillary tube to oscillate and possibly also the 
outer capillary tube, if the outer capillary tube is also made 
of a flexible material. 
The position of the inner tube relative to the outer tube is 
not critical, and the inner tube may be extended or retracted 
up to about 1.25 mm from the end of the outer tube. 
However, optimum performance is obtained either with the 
two tubes approximately flush with one another, or the inner 
tube extending slightly beyond the end of the outer tube, 
depending on the gas flow rates. The oscillation causes the 
generation of a high frequency standing wave along a 
portion of the length of the inner capillary tube which then 
transmits the energy to the liquid stream causing the breakup 
of the liquid sample stream exiting the inner capillary tube 
into small liquid drop sizes. 
Accordingly, it is an object of the present invention to 
provide an oscillating capillary nebulizer with electrospray 
5 which is capable of generating aerosol at higher liquid flow 
rates and of higher water percentages than prior electrospray 
devices. 
It is another object of the present invention to provide an 
oscillating capillary nebulizer with electrospray ionization 
10 which is capable of producing a primary aerosol distribution 
having smaller mean droplet sizes than prior known pneu-
matic nebulizers. 
In reference to the electrospray technique, as the liquid 
sample emerges from the inner capillary, it is subjected to a 
very strong electric field in the vicinity of the distal end of 
the inner capillary. The strong field polarizes the liquid 20 
sample at the end of the inner capillary, causing an elongated 
liquid filament to be formed and then normal surface tension 
forces produce instabilities which snap off a length of the 
filament to form small droplets. Inasmuch as the snapping 
off of the filament occurs while the filament is in the strong 25 
electric field, the droplet formed is highly charged electri-
cally. The electric fields acting on the charged droplet tend 
It is a further object of the present invention to provide an 
oscillating capillary nebulizer with electrospray which is 
15 
capable of being used with bench top liquid chromatograph 
and mass spectrometer instrument systems and microflow 
separation techniques such as LC and CE combined with 
ICP/AES, ICP/MS, FT-IR, FT-MS and MS/MS. 
to accelerate the droplet away from the distal end of the 
inner capillary. 
If the liquid sample is volatile, it tends to evaporate and 30 
the droplet diminishes in size. If no charge leaks off the 
droplet while it is evaporating, the charge density on the 
surface of the droplet increases. When the surface charge 
density is low, the surface tension forces which tend to hold 
the droplet together in its spherical shape exceed the electro- 35 
repulsive forces caused by the surface density, and the 
droplet retains a spherical shape. However, as the droplet 
evaporates without loss of charge, there is a point reached 
where the electro-repulsive forces exceed the attractive 
surface tension forces, whereupon the droplets become 40 
unstable and tend to break up into two or more smaller 
charged droplets. 
The present invention improves upon the prior art, and 
produces aerosol particles at higher liquid flow rates than is 
known possible with the prior art devices. The typical prior 45 
art electrospray nebulizers generally operate at liquid flow 
rates of approximately 1 µl/min. to 15 µl/min. Another type 
Yet another object of the present invention is to provide an 
oscillating capillary nebulizer with electrospray which is 
capable of achieving better control over the particle size and 
particle size distribution of aerosol droplets generated. 
It is another object of the present invention to provide an 
oscillating capillary nebulizer with electrospray which is 
capable of achieving results similar to those achieved by 
ultrasonic nebulizers at greatly reduced costs. 
It is another object of the present invention to provide an 
oscillating capillary nebulizer with electrospray which is 
capable of operating over a wide range of liquid flow rates. 
Another object of the present invention is to provide an 
oscillating capillary nebulizer with electrospray that signifi-
cantly increases the dynamic range of measurement. 
Yet another object of the present invention is to provide an 
oscillating capillary nebulizer with electrospray which can 
perform well at higher concentration percentages of water, 
up to utilizing 100% water. 
It is yet another object of the present invention to provide 
an oscillating capillary nebulizer with electrospray which is 
effective at both atmospheric and reduced pressure. 
These and other objects of the present invention will be 
apparent from the detailed description of the invention. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. l(a) illustrates a cross-sectional side view of the 
oscillating capillary nebulizer used in electrospray of the 
present invention. 
FIG. l(b) illustrates a cross-sectional side view of the 
oscillating capillary nebulizer of the present invention, with 
adjustable inner capillary position. 
FIG. 2 illustrates a cross-sectional view of the coaxial 
arrangement of the inner and outer capillary tubes of the 
present invention. 
FIG. 3 illustrates a trace of the ultrasonic wave observed 
on the inner capillary tip of the oscillating capillary nebu-
lizer with electrospray of the present invention. 
of electrospray nebulizer, disclosed in Henion et al., uses the 
direct interaction between gas velocity and liquid jet to 
cause a breakup of the liquid jet into liquid particles. By 50 
operating over a wider range of liquid flow rates than the 
prior art electrospray nebulizers, the OCN nebulizer with 
electrospray of the present invention is able to achieve 
greater control over particle size and particle size 
distribution, more uniform particle sizes and smaller mean 55 
particle sizes than before. Furthermore, the particle drop 
sizes found are only slightly influenced by the surface 
tension or viscosity of the solvents used with typical pneu-
matic nebulizers. 
FIG. 4 illustrates the oscillating capillary nebulizer with 
electrospray of the present invention combined with an 
60 LC/MS system (Extrel Benchmark). The present invention also overcomes the deficiencies of 
the prior electrospray devices. It allows for greater toleration 
of liquid flow rates, of up to 200 µl/min as opposed to 15 
µl/min for the prior electrospray devices. It allows for higher 
water percentage in the liquid flow, up to 100%. It provides 
a greater dynamic range of up to 3 orders of magnitude. It 65 
is also not as limited in the inclusion of additives to the 
liquid. 
FIG. 5 illustrates the oscillating capillary nebulizer of the 
present invention and an interface for either an ICP/AES or 
an ICP/MS system. 
FIG. 6 illustrates the mass spectrum of horse heart myo-
globin with a standard ESI source. 
FIG. 7 illustrates the mass spectrum of horse heart myo-
globin (OCN/ESI). 
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FIG. S illustrates the mass spectrum of Cd(N03 ) 2 in 10% 
water. 
FIG. 9 illustrates the mass spectrum of Cd(N03) 2 in 100% 
water. 
FIG. 10 illustrates the mass spectrum of reserpine (OCN/ 5 
ESI). 
FIG. 11 illustrates the reserpine signal with respect to 
concentration. 
FIG. 12 illustrates the reserpine signal with respect to 10 
water percentage. 
FIG. 13 illustrates the reserpine signal with respect to 
water to flow rate. 
8 
tube 2 to be moved in the axial direction such that the 
distance that the distal end 40 of the outer capillary tube 2 
extends in relation to distal end 7 of the inner capillary tube 
1 can be adjusted. 
In operation, the gas flow velocity must contain sufficient 
kinetic energy to cause turbulence of the gas stream around 
~he di.s~al .end 7 of the inner capillary tube and impart 
mstabihty m the system. This gas flow velocity is a function 
of the gas flow rate and the size of the annular space 6 
betw~en the capillary tubes. In order to create this instability, 
sufficient gas velocity for a particular gas is needed to cause 
the inner capillary tube to oscillate and generate an ultra-
sonic standing wave along the axial direction of at least a 
portion of the inner capillary tube, as illustrated in FIG. 3. 
DETAILED DESCRIPTION OF IBE 
INVENTION 
. FIG~. la and lb are two embodiments of the present 
mvent10n 10. The two embodiments are generally similar, 
and described in reference to FIG. lb in detail below. 
15 This instability will also cause the inner capillary tube to 
transversely oscillate at a low frequency, and depending on 
how the system is set up, may also cause the outer capillary 
tube to oscillate if also made of a flexible material. The 
oscillation of the inner capillary tube is observable in both 
The configuration of FIG. la differs from that of FIG. lb 
~n that post S provides a gas inlet to annular space 6, shown 
m FIG. 2 via a tee 150, preferably a Swagelok™ Union Tee. 
Additionally, ferrules 3, 4, Sa friction-fit capillary tubes 1, 
2 and port S, respectively, which ferrules 3, 4, Sa are held 
secure by nuts 152, 154, 156, respectively. Further, as 
described below, as shown in FIG. la, tubes 1, 2 are left in 
the same relative position after initial adjustment. 
20 the transverse and longitudinal directions. The oscillation in 
the transverse direction is typically in the range of 200 Hz 
to 1400 Hz and is audible. However, it is the longitudinal 
oscillation that appears to generate the standing wave. The 
oscillation is in the megahertz to tens of megahertz range 
. As s~own in FIGS. l(b)-3, the oscillating capillary nebu-
hzer with electrospray 10 of the present invention is com-
prised of a pair of coaxial inner and outer capillary tubes 1, 
2. The capillary tubes are friction-fit mounted by way of 
PEEK tubing ferrules 3 and 4 near their proximal ends 3a 
~nd 4a, respectively. This fitting allows for interchangeabil-
~ty and .replacement of capillary tubes. Liquid sample 
mtroduct10n, generally from a liquid chromatography, is 
provided by liquid flow path 5 via the inner capillary tube 1. 
25 and is inaudible. In one set of conditions the observed 
wavelength of the longitudinal oscillation was about 5 µm. 
The longitudinal oscillation of the inner capillary tube 
c~uses a breakup of the liquid jet into uniform liquid drop 
sizes. The oscillating capillary nebulizer with electrospray 
30 of the present invention is capable of operating to produce 
aerosol over a liquid microflow rate range of up to 200 µ1. 
The gas flow rate range is generally from 0.5 liters/min. to 
~ .0 liters/min. The instability of the inner capillary tube or 
mner and outer capillary tubes is a function of the location 
35 of the distal end 7 of the inner capillary tube 1 with respect 
to the distal end 40 of outer capillary tube 2, the dimensions 
of the inner and outer capillary tubes 1 and 2, and the gas and 
liquid flow rates. A gas flow path is provided by the annular space 6 between 
the outer diameter of the inner capillary tube 1 and the inner 
diameter of the outer capillary tube 2. The gas enters the gas 
flow path through a port S in the side of the outer capillary 40 
tube. At least the inner capillary tube 1 is made of a flexible 
material, preferably polyimide coated fused silica from 
Polymicro Technology, Inc., which adds flexibility and 
makes the tubing less brittle. The outer capillary tube 2 may 
also, but need not, be made of a flexible material. The 45 
dimensions of the inner capillary tube 1 are such that a flow 
of the liquid sample can be provided at flow rates as low as 
50 µl/min. and less and also up to 200 µl/min. 
A connector 11 is shown for allowing connection of the 
liquid sample input of the nebulizer to a ZDV union. The 
nebulizer is further constructed with a rotating connector 
ring 12 sealed by 0-ring 13. 
50 
A source 100 of the electrical potential is connected to the 
inn~r capillary tube 1. For negative ion operation, the inner 55 
capillary tube 1 may be kept in the range of -2000 to -3500 
volts and preferably in the range of -2500 to -3000 volts; 
and for positive operation in the range of +2000 to +3500 
volts, preferably in the range of +2500 to +3000 volts. The 
actual voltage applied will vary dependent upon the analyte 60 
involved. 
With reference to FIG. l(a), the inner and outer tubes 1 
2 are left in the same relative position after initial adjust~ 
ment. With reference to FIG. l(b), the inner and outer 
capillary tubes 1, 2 are arranged to provide relative move- 65 
ment between them in the axial directions. Preferably, a 
rotating connector ring or fitting 9 allows the outer capillary 
FIG. 4 illustrates the oscillating capillary nebulizer with 
electrospray ionization of the present invention interfaced 
with a Benchmark™ mass spectrometer for LC/MS work. 
The interface consists of a nozzle SO and two skimmers S2 
S4 which are all made of stainless steel. The aerosols 200 
generated by the oscillating capillary nebulizer are intro-
duced into the mass spectrometer through the nozzle SO, first 
and second skimmers S2, S4, which are all biased at different 
potentials to create electric gradient to guide the charged 
aerosols. The mass spectrometer uses a quadruple 90 as its 
mass analyzer and an electron multiplier 100 as the signal 
generator. The interface region is maintained at vacuum 
pressure by a pair of rotary vacuum pumps 110, 112 and the 
mass analyzer region is maintained at vacuum pressure by a 
turbomolecular pump 120. In order to maintain the desired 
vacuum pressure in the mass analyzer region, it may be 
necessary to use more than one such pump. 
In FIG. 5, the oscillating capillary nebulizer 10 of the 
present invention is shown with an interface for either an 
ICP/AES or ICP/MS system for operation at atmospheric 
pressure. In this application, the aerosol of the oscillating 
capillary nebulizer is introduced into a spray chamber 32 
which is coupled with transfer tubing 34 leading to either the 
ICP/AES or the ICP/MS system. The OCN can also be used 
as an interface between micro LC to ICP-AES or ICP-MS. 
EXPERIMENTAL 
The oscillating capillary nebulizer with electrospray of 
the present invention was constructed as described above 
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with reference to FIGS. l(a) and (b) with lengths of the 
liquid and gas capillary tubes 1, 2 being 80±10 mm. and 
30±10 mm., respectively. In the fixed version of the OCN, 
as shown in FIG. l(a), the relative capillary positions are 
established by adjustment of the individual capillaries, 5 
which are then locked in position. In the adjustable version 
of the OCN, as shown in FIG. l(b), the rotating connector 
fitting 9 was used, when necessary, to adjust the position of 
the outer capillary tube 2 relative to the one in the axial 
direction relative to the position of the inner capillary tube 
10 1. The adjustable distance between the tips of both capil-
laries was in the range of -2 mm. to +3 mm.; the negative 
values indicating that the inner capillary tube was retracted 
inside the gas capillary tube, and the positive values indi-
cating that the distal end of the liquid capillary tube was 
extending beyond the distal end of the gas capillary tube. 15 
The capillary tubes were friction-fit mounted by PEEK 
tubing ferrules allowing for easy change of either or both 
capillary tubes. In this way, the four diameters of the 
capillary tubes, namely, the inner and outer diameters of 
each tube could be manipulated, simply by swapping out the 20 
capillary tubes. 
The liquid samples were introduced into the liquid cap-
illary tube 1 by a Hewlett-Packard Model 1090 Liquid 
Chromatography Pump which is capable of delivering con-
tinuous liquid flows with 1 µl/min. resolution. At liquid flow 25 
rates of 10 µl/min. or less to cancel pulsation of the pump, 
a short length of 20 µm i.d. silica capillary tube was placed 
10 
For a given analyte concentration the analyte mass con-
tained in the aerosol is directly proportional to aerosol 
volume. Moreover, the evaporation and vaporization rates of 
particles are inversely related to the volume-to-surface area 
ratios. The lower the D3 2 , the faster evaporation and vapor-
ization occur, resulting' in a higher signal. The drop size 
distribution obtained by the Fraunhoffer scattering is percent 
volume distribution which can be readily transposed into a 
mass distribution and knowing the solvent and analyte 
density. 
In our experiments, a lens of 63 mm focal length was used 
and particle size range observed was 1.22 to 118 µm. The 
Malvern instrument was operated using the "independent 
mode" option. The primary aerosols were perpendicularly 
introduced into the helium/neon laser beam directly from the 
nebulizer at a distance of 14 mm for all measurements. Each 
measurement was made in triplicate and all data were an 
average of the three measurements. The information pro-
vided by the particle sizer is percent volume based on 
drop-size distribution. Argon was used as the nebulizer gas 
for all nebulizers. Distilled de-ionized water, and methanol 
were used as solvents. 
FIGS. 6 and 7 illustrate the ability of the oscillating 
capillary nebulizer ( OCN) of the present invention including 
electrospray injection (ESI) to generate standard electro-
spray mass spectra. FIG. 6 is a mass spectrum of horse heart 
myoglobin obtained from a conventional electrospray 
source. FIG. 7 is a mass spectrum of the same compound 
obtained from OCN/ESI. The instrument parameters of 
acquiring data are the same for the two spectra: 50:50 
in line between the pump and the liquid capillary 1. A 
Matheson mass flow controller Model 8270 was used to 
control the nebulizer gas flow rate. The back pressure for the 
gas flow rate was 150-200 psi for the oscillating capillary 
nebulizer of the present invention, unless otherwise speci-
fied. 
30 Methanol; water with 1 % acetic acid as the solvent; and the 
concentration of myoglobin was 5 µM. The spectrum pro-
duced by OCN/ESI correlates closely with that from con-
ventional electrospray source in terms of peak relative 
A Malvern (Southborough, Mass.) 2600c Droplet and 
Particle Sizer was used for measuring aerosol drop size 35 
distributions. This instrument consists of a helium/neon 
intensities and mass positions. Therefore, this shows the 
ability of OCN/ESI to generate standard electrospray mass 
spectra without distorting the appearance of the spectra. 
FIG. 8 shows that OCN/ESI cannot only produce elec-
trospray spectra in organic solvent of 90% methanol and 
10% water, as do conventional ESI sources, but, as shown in 
40 FIG. 9, it can also generate spectra in 100% aqueous 
solution, in which conventional electrospray sources do not 
perform well. As can be observed, the consistency of the 
spectra by OCN/ESI from both organic and aqueous solu-
laser beam, a receiver lens, and a series of 31 semi-circular 
concentric annular detectors in addition to a central detector. 
The operating principle of the Malvern system is based on 
the Fraunhoffer diffraction theory. B. B. Wiener, "Particle 
and Droplet Sizing Using Fraunhoffer Diffraction," in Mod-
ern Methods of Particle Size Analysis, H. G. Barth, ed. John 
Wiley & Sons, N.Y. (1984). By measuring the scattering of 
the small forward angle, histogram plots of volume percent 
versus particle size of aerosol can be provided. 45 
Unfortunately, the measurable particle range is limited to 1.9 
µm to 176 µm by this theory. Especially for 1-2 µm particles, 
the errors can be 20% or more. In spite of these limitations, 
laser Fraunhoffer scattering systems have been used exten-
sively for measuring aerosol from atomic spectrometric 
systems and have inherent advantages. See also, D. R. 
Wiederin and R. S. Houk, Appl. Spectrosc., 45, 1408, 
(1991); and J. W. Olesik, J. A Kinzer and B. Harkelroad, 
Anal. Cheim, 66, 2022, (1994). It is non-intrusive, precise, 
absolute, and fast. 
The Fraunhoffer particle sizer provides a great deal of 
information about aerosol size distribution. To relate the 
aerosol properties to the analytical atomic spectrometric 
signals, two important parameters are used: the Sauter Mean 
Diameter (D3 2 ) and the drop size distribution. The Sauter 
mean diamete'r is a measure of a total volume of particles in 
a distribution compared to the surface area. Mathematically, 
it can be expressed as the following formula: 
D3 f{:E.dj 3 N/:E.dj 2NJ 
where da is the jth diameter and Nj is the number of particles 
of diameter Dj. 
tions is very good. 
FIG. 10 is the OCN/ESI spectrum for the compound 
reserpine. Reserpine was the model compound to test the 
quantification aspect of the OCN/ESI because it has a very 
clean electrospray mass spectrum with the molecular ion 
(m/z=609) as the only significant peak. The single ion 
50 monitoring (SIM) data acquisition mode was used to inves-
tigate the ion signals from this single mass and the results of 
FIGS. 11-13 are all from this peak of reserpine. 
FIG. 11 is a calibration curve for the reserpine signal 
versus its concentration using a solvent of 80% methanol 
55 and 20% water. The linear range in a log-log plot is more 
than three orders of magnitude. This is much better than 
those from conventional electrospray sources, which usually 
have a range of two orders of magnitude. 
FIG. 12 is the graph of the reserpine signal versus 
60 percentage of the water in the solvent including 100% to 0% 
methanol. This also illustrates the ability of OCN/ESI to 
work in different solvents without major changes in signal. 
The water percentages are from 0 to 100%, and the signals 
remained stable; this is highly desirable in gradient liquid 
65 chromatography applications. 
FIG. 13 addresses the ability of OCN/ESI to handle much 
higher liquid flow rates than conventional electrospray 
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sources. Conventional sources usually require a solvent flow 
rate of less than 15 µl/min and are incompatible with flow 
rates of standard BPLC (high performance liquid 
chromatography). On the other hand, OCNIESI can handle 
a flow rate as high as 200 µl/min without significant loss of 5 
signals. This aspect of the present invention is a large 
advantage over the present, conventional sources. 
From the above discussion, it can be seen that the above 
described oscillating capillary nebulizer with electrospray is 
capable of operating at micro flow liquid flow rates which are 10 
significantly higher than the flow rates at which known 
conventional and electrospray devices may operate. Our 
nebulizer is also capable of producing a primary aerosol 
distribution having a mean droplet diameter which is smaller 
and more uniform than known nebulizers. Aerosol particle 15 
size and particle size distribution can be controlled by 
varying the dimensions of the inner and outer capillary 
tubes, by varying the location of the distal end of the inner 
capillary tube with respect to the location of the distal end 
12 
and the inner diameter of the outer capillary tube, said 
proximal end of said second flexible inner capillary 
tube being open for allowing a liquid sample to be 
introduced into said second flexible capillary tube, and 
wherein gas is introduced through the gas flow opening 
and the liquid sample is introduced through the opening 
in said proximal end of said second flexible capillary 
tube at flow rates sufficient to cause liquid being 
projected from said distal end of said second flexible 
capillary tube to be nebulized due to both said electrical 
field and oscillation of said second flexible capillary 
tube caused by the gas flow, and wherein a standing 
wave is generated along the axial direction of at least a 
portion of said second flexible inner capillary tube. 
2. A nebulizer for nebulizing a liquid sample provided to 
said nebulizer according to claim 1 wherein said nebulizer 
further comprises means for effecting relative movement 
between said first outer flexible capillary tube and said 
second flexible inner capillary tube in the coaxial directions, 
20 wherein said means for effecting relative movement is 
connected to said first capillary tube at a location near the 
proximal end of said first capillary tube and to said second 
flexible capillary tube at a location near the proximal end of 
said second flexible capillary tube, said means for effecting 
of the outer capillary tube, and by varying the liquid and gas 
flow rates. Our nebulizer is operable over low liquid flow 
rates as low as 1 µl/min and less, as well as up to 200 µl/min. 
The preferable range for gas flow rates is approximately 
from 0.5 liters/min. to 1.0 liters/min. The preferred inner 
diameter of the inner capillary tube ranges from approxi-
mately 25 micrometers to approximately 103 micrometers. 
The preferred inner diameter of the outer capillary tube 
ranges from approximately 180 micrometers to 350 
micrometers. The preferred annular spacing between the 
outer diameter of the inner capillary tube and the inner 
diameter of the outer capillary tube ranges from approxi-
mately 25 micrometers to approximately 75 micrometers. 
However, more important than the absolute values for these 
operating parameters is that the inner liquid capillary tube be 
made of a flexible material and that the annular spacing 
between the inner and outer capillary tubes in combination 
with the gas flow rate be such that the velocity of the gas 
flow imparts instability in the nebulizer causing the inner 
capillary tube to oscillate and generates a high frequency, 
ultrasonic standing wave along at least a portion of the liquid 40 
capillary tube. 
Although the present invention has been described with 
reference to preferred embodiments, it will be apparent to 
those skilled in the art that variations and modifications of 
25 relative movement substantially enclosing the proximal end 
of said first capillary tube to form a chamber within said first 
capillary tube, said second flexible capillary tube passing 
through said means for effecting relative movement to form 
the connection between said second flexible capillary tube 
30 and said means for effecting relative movement. 
3. A nebulizer for nebulizing a liquid sample provided to 
said nebulizer according to claim 1 wherein said first and 
second capillary tubes are comprised of fused silica. 
4. A nebulizer for nebulizing a liquid sample provided to 
35 said nebulizer according to claim 1 wherein said inner 
diameter of said second flexible capillary tube is sufficiently 
small to create a liquid stable flow at the liquid flow rate at 
which the liquid sample is introduced into said proximal end 
of said second flexible capillary tube. 
5. A nebulizer for nebulizing a liquid sample provided to 
said nebulizer according to claim 1 wherein said nebulizer 
produces an aerosol at a liquid flow rate which extends from 
less than 1 µl/min up to 200 µl/min. 
the present invention are within the spirit and scope of the 45 
6. A nebulizer for nebulizing a liquid sample provided to 
said nebulizer according to claim 1 wherein the particle size 
and particle size distribution can be controlled by varying 
the dimensions of said first outer capillary tube and said 
second flexible inner capillary tube. 
present invention. 
What is claimed is: 
1. A nebulizer for nebulizing a liquid sample provided to 
said nebulizer, said nebulizer comprising: 7. A nebulizer for nebulizing a liquid sample provided to 
a first outer capillary tube leaving an inner diameter and 
an outer diameter, a second flexible inner capillary tube 
having an inner diameter and an outer diameter, said 
outer diameter of said second flexible capillary tube 
being smaller than said inner diameter of said first 
capillary tube, said second capillary tube being coaxi-
ally arranged within said first capillary tube such that 
50 said nebulizer according to claim 2 wherein the particle size 
and particle size distribution of the nebulized liquid can be 
varied by adjusting said means for effecting relative move-
ment to thereby vary the distance between the distal end of 
said first outer capillary tube and the distal end of said 
55 second flexible inner capillary tube. 
an annular spacing exists between the outer diameter of 
said second flexible capillary tube and the inner diam-
eter of said firs capillary tube, means for mounting said 
second flexible capillary tube and said first capillary 60 
tube in the coaxial arrangement, said second flexible 
capillary tube having a distal end and a proximal end, 
means for creating and electrical field in the vicinity of 
the distal end of said second flexible capillary tube, said 
means for mounting having a gas flow opening formed 65 
therein for allowing gas to flow into the space between 
the outer diameter of the flexible inner capillary tube 
8. A nebulizer for nebulizing a liquid sample provided to 
said nebulizer according to claim 1 wherein the particle size 
and particle size distribution of the nebulized liquid can be 
varied by changing the liquid and sample gas flow rates. 
9. A method of nebulizing a liquid sample comprising the 
steps of: 
(a) mounting a second flexible inner capillary tube inside 
of a first outer capillary tube in a coaxial relationship, 
said first outer tube having a and inner diameter, and 
outer diameter, an outer diameter, a proximal end and 
a distal end wherein said outer diameter of said second 
flexible inner capillary tube is smaller than the inner 
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diameter of said first outer capillary tube such that an 
annular spacing exists between the outer diameter of 
said second flexible inner capillary tube and the inner 
diameter of said first outer capillary tube; 
(b) creating and electrical field in the vicinity of the distal 5 
end of said second flexible inner capillary; 
( c) introducing the liquid sample into said second flexible 
inner capillary tube at a predetermined liquid flow rate 
such that the liquid sample flows toward the distal end 
of said flexible inner capillary tube; and 10 
( d) introducing a gas into the annular spacing at a prede-
termined gas flow rate sufficient to cause liquid being 
projected from said distal end of said second flexible 
inner capillary tube to be nebulized due to both said 
14 
electrical field and oscillation of said second flexible 
inner capillary tube caused by the gas flow. 
10. A method for nebulizing a liquid according to claim 9, 
wherein said first outer capillary tube is flexible. 
11. A method of nebulizing a liquid according to claim 9 
wherein said gas is selected from the group consisting of 
argon, air, helium, nitrogen and oxygen. 
12. A method of nebulizing a liquid according to claim 9 
wherein said nebulizer produces an aerosol at a liquid flow 
rate which extends from less than 1 µl/min up to 200 µl/min. 
13. A method of nebulizing a liquid according to claim 9 
wherein said gas flow rate is between 0.5 liters/min. and 1.0 
liters/min. 
* * * * * 
